DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT substitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.

NOTE: The haematology contents of this resource is currently under review and in the process of being updated.

Therapy-Oriented Precision Oncology Guidelines for Recommending Anti-cancer PHarmaceuticals

Database version: 20260430 (AU)

271
Gene and protein biomarkers

79
Combination biomarkers

13
Complex biomarkers

1198
Simple mutations

479
Variant groups

188
Protein expressions

185
Amplification deletions

355
Fusions and Rearrangements

5
Splice variants

7
Methylations

27
Germline mutations

46
Common cancers

82
T1

86
T2

167
T3

290
T4

10
R1

174
R2

25
Less common cancers

19
T1

12
T2

44
T3

106
T4

0
R1

22
R2

179
Rare cancers

39
T1

46
T2

124
T3

377
T4

6
R1

153
R2

© 2020-2026, Garvan Institute of Medical Research, University of Sydney, and Omico
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst NSW 2010, Australia.